玻璃体荧光光度测定法的理论与方法
Theory and methodology of vitreous fluorophotometry.
作者信息
Maurice D M
出版信息
Jpn J Ophthalmol. 1985;29(2):119-30.
PMID:4046221
Abstract
The technique of vitreous fluorophotometry is discussed with particular reference to the uncertainty in the measurements resulting from instrumental and biological factors. The methods proposed for reducing the interference from these factors are explained. Various optical systems for carrying out the measurements are described. The suggestion is made that the technique could be much more accurate and safe if fluorescein was replaced by a dye which fluoresced at longer wavelengths and was more rapidly eliminated from the blood.
摘要
本文讨论了玻璃体荧光光度测定技术，特别提及了由仪器和生物因素导致的测量不确定性。文中解释了为减少这些因素干扰而提出的方法。描述了用于进行测量的各种光学系统。有人提出，如果用一种在更长波长下发出荧光且能更快从血液中消除的染料取代荧光素，该技术可能会更加准确和安全。
相似文献
1
Theory and methodology of vitreous fluorophotometry.玻璃体荧光光度测定法的理论与方法
Jpn J Ophthalmol. 1985;29(2):119-30.
2
Pharmacokinetics of fluorescein in the vitreous.荧光素在玻璃体中的药代动力学。
Invest Ophthalmol Vis Sci. 1981 Oct;21(4):542-9.
3
Vitreous variation in vitreous fluorophotometry.玻璃体荧光光度测定法中的玻璃体变化
Ann Ophthalmol. 1982 Mar;14(3):245-9.
4
Role of fluorescein glucuronide and its metabolism in vitreous fluorophotometry.
Exp Eye Res. 1987 Feb;44(2):209-15. doi: 10.1016/s0014-4835(87)80005-2.
5
Barriers to fluorescein and protein movement.
Jpn J Ophthalmol. 1985;29(2):131-8.
6
Pharmacokinetic interpretation of vitreous fluorophotometry.
Invest Ophthalmol Vis Sci. 1983 Oct;24(10):1374-81.
7
Vitreous fluorophotometry in aphakic or pseudophakic eyes with persistent cystoid macular edema.无晶状体或人工晶状体眼合并持续性黄斑囊样水肿的玻璃体荧光光度测定
Jpn J Ophthalmol. 1985;29(2):146-52.
8
Fluorophotometry in juvenile-onset diabetes: long-term follow-up.
Jpn J Ophthalmol. 1985;29(2):139-45.
9
The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
Invest Ophthalmol Vis Sci. 1983 Jan;24(1):57-65.
10
Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
Acta Ophthalmol Suppl (1985). 1993(211):1-52.
引用本文的文献
1
Non-invasive molecular tracking method that measures ocular drug distribution in non-human primates.一种非侵入性的分子追踪方法，用于测量非人类灵长类动物的眼部药物分布。
Commun Biol. 2020 Jan 8;3(1):16. doi: 10.1038/s42003-019-0731-9.
2
Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study.
Graefes Arch Clin Exp Ophthalmol. 1991;229(5):442-6. doi: 10.1007/BF00166307.
Zotero 插件